FABP4 and metabolic dysfunction-associated steatotic liver disease: We also analyzed the mRNA expression of FABP4 and SREBP1, which is linked to liver lipid storage, liver steatosis, liver lipogenesis, and NAFLD pathogenesis [39,48].